# Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

> **NCT06364215** · NA · TERMINATED · sponsor: **Jorge Romero** · enrollment: 198 (actual)

## Conditions studied

- Atrial Fibrillation Paroxysmal

## Interventions

- **DEVICE:** Farapulse PFA, Pulmonary Vein Isolation alone
- **DEVICE:** Farapulse PFA, Pulmonary Vein Isolation and Left atrial Posterior Wall Isolation

## Key facts

- **NCT ID:** NCT06364215
- **Lead sponsor:** Jorge Romero
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-11-16
- **Final completion:** 2025-11-16
- **Target enrollment:** 198 (ACTUAL)
- **Why stopped:** Insufficient enrollment related to ILR coverage barriers and the resulting inability to meet timelines with the available funding.
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06364215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06364215, "Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06364215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*